143,826 Shares in Sotera Health (NASDAQ:SHC) Acquired by Clearline Capital LP

Clearline Capital LP acquired a new stake in shares of Sotera Health (NASDAQ:SHC) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 143,826 shares of the company’s stock, valued at approximately $1,707,000. Clearline Capital LP owned 0.05% of Sotera Health at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. CWM LLC boosted its stake in shares of Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after buying an additional 993 shares during the last quarter. Point72 DIFC Ltd lifted its holdings in Sotera Health by 556.6% in the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock valued at $78,000 after acquiring an additional 5,544 shares during the period. Acadian Asset Management LLC boosted its position in Sotera Health by 728.0% in the 2nd quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after purchasing an additional 8,248 shares in the last quarter. Sandia Investment Management LP acquired a new stake in shares of Sotera Health during the 1st quarter worth approximately $120,000. Finally, Securian Asset Management Inc. increased its holdings in shares of Sotera Health by 23.0% during the 1st quarter. Securian Asset Management Inc. now owns 10,178 shares of the company’s stock valued at $122,000 after purchasing an additional 1,900 shares in the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Stock Performance

SHC opened at $16.76 on Friday. The firm’s fifty day simple moving average is $15.24 and its two-hundred day simple moving average is $12.94. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.44. The company has a market cap of $4.75 billion, a price-to-earnings ratio of 88.22 and a beta of 2.07. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Monday, August 5th. The company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The firm had revenue of $277.00 million for the quarter, compared to analyst estimates of $266.45 million. During the same period last year, the company posted $0.19 EPS. Sotera Health’s quarterly revenue was up 8.6% compared to the same quarter last year. Equities analysts anticipate that Sotera Health will post 0.64 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $15.03, for a total value of $150,300,000.00. Following the transaction, the director now owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 55.12% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

SHC has been the topic of several analyst reports. Barclays raised their price target on shares of Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research report on Tuesday, August 6th. Royal Bank of Canada restated an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research report on Tuesday, August 6th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $15.70.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.